CDT Equity Inc. (CDT): auditor change — CDT Equity restates Q1 2025 financials; $0.4M milestone misclassified as R&D

CDT Equity Inc.

On Aug 8, 2025, CDT Equity determined its unaudited Q1 2025 financials should no longer be relied upon.
$0.4 million in milestone payments to Sarborg Limited were misclassified as R&D expense instead of an acquired diagnostic asset.
The restatement requires amendments to the Q1 2025 10-Q, affecting balance sheet, income statement, and cash flows.
The Audit Committee and independent accounting firm CBIZ CPAs agreed on the restatement.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

CDT Equity Inc. reported that prior financial statements should not be relied upon.

Action: non reliance
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On August 8, 2025, CDT Equity Inc. (the “Company”) determined, after discussions with its advisors and CBIZ CPAs P.C., the Company’s independent registered public accounting firm, that the Company’s previously issued unaudited financial statements, and notes related thereto, for the Subject Period (as defined below) should no longer be relied upon due to the restatement described below

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

CDT Equity Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-023840

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.